Fexofenadine HCl and Pseudoephedrine HCI
- Product NDC
- 43598-823
- Requested package NDC
- 43598-823-40
- 11-digit product format
- 435980823
- Labeler code
- 43598
- Product ID
- 43598-823_d024126e-de41-3d5e-73d8-bbb2623037e6
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Fexofenadine HCl and Pseudoephedrine HCI
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Dr. Reddy's Laboratories Inc.
- Application
- ANDA076667
- Marketing category
- ANDA
- Marketing start
- 2019-07-18
- Substance
- FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE
- Active strength
- 60; 120 mg/1; mg/1
- Pharmacologic classes
- Adrenergic alpha-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-Adrenergic Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
NDC auxiliary status#
Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status. Browse every current auxiliary row, including rows without a usable NDC. · Browse every captured source and parsed snapshot.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| unfinished package | package | 43598-823 | 43598-823-40 | UNFINISHED | Active or certified unfinished drug listing | 2026-07-31 |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A076667-001 | FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE | FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE | 60MG;120MG | TABLET, EXTENDED RELEASE / ORAL | 2014-11-18 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A076667-001 | FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE | 60MG;120MG | TABLET, EXTENDED RELEASE / ORAL | 2014-11-18 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Fexofenadine HCl and Pseudoephedrine HCI | FEXOFENADINE HCL AND PSEUDOEPHEDRINE HCI | Dr. Reddy's Laboratories Limited | 728632be-7e5c-2d06-4c95-bc8ecc9be2ec | 2024-12-19 | Warnings | 076667 ANDA076667 |
| Allergy and Congestion | FEXOFENADINE HCL AND PSEUDOEPHEDRINE HCI | Rite Aid Corporation | 90e1aa06-b769-e8ac-af88-1d6a256b9487 | 2020-05-19 | Warnings | 076667 ANDA076667 |
| Fexofenadine HCl and Pseudoephedrine HCI | FEXOFENADINE HCL AND PSEUDOEPHEDRINE HCI | Dr. Reddy's Laboratories Inc. | 6fd05737-d996-b5b6-dccf-bc179a9d606c | 2019-09-09 | Warnings | 076667 ANDA076667 43598-823 |
| Fexofenadine HCl and Pseudoephedrine HCI | FEXOFENADINE HCL AND PSEUDOEPHEDRINE HCI | The Kroger Co. | 8cf0b878-ec13-fd44-d56f-f44af7c249ed | 2018-10-01 | Warnings | 076667 ANDA076667 |
| Fexofenadine HCl and Pseudoephedrine HCI | FEXOFENADINE HCL AND PSEUDOEPHEDRINE HCI | The Kroger Co. | cb9e98a9-74e6-7a3e-9c5e-3bc35c4bbca6 | 2017-12-07 | Warnings | 076667 ANDA076667 |
| Fexofenadine HCl and Pseudoephedrine HCI | FEXOFENADINE HCL AND PSEUDOEPHEDRINE HCI | HEB | 0de7fc37-7f46-4e98-d5ac-d31a3c313a62 | 2017-12-07 | Warnings | 076667 ANDA076667 |
| Fexofenadine HCl and Pseudoephedrine HCI | FEXOFENADINE HCL AND PSEUDOEPHEDRINE HCI | CVS Pharmacy | 3e295047-1a46-a0d8-2e3f-ec4086f5aedb | 2015-08-24 | Warnings | 076667 ANDA076667 |
| Fexofenadine HCl and Pseudoephedrine HCI | FEXOFENADINE HCL AND PSEUDOEPHEDRINE HCI | Walgreens Company | 37c1ce51-fb5d-7ebf-bbcd-1b2fd41d45b3 | 2015-08-04 | Warnings | 076667 ANDA076667 |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Fexofenadine HCl and Pseudoephedrine HCI
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| FEXOFENADINE HYDROCHLORIDE | 60 mg/1 |
| PSEUDOEPHEDRINE HYDROCHLORIDE | 120 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 2S068B75ZU | Internal UNII lookup |
| 6V9V2RYJ8N | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 997406 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 6fd05737-d996-b5b6-dccf-bc179a9d606c | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| ba088a92-ab5e-b2d4-e908-f5ea691b7587 | Product name | 7 | 20210201 |
| 0fdb98e2-b951-a1ce-5715-2b187ba500ef | Product name | 4 | 20170718 |
| e974e22d-8688-7d92-1e87-40c1079e170c | Product name | 3 | 20151125 |
| e8718272-64cb-4436-969b-176c3067c8f4 | Product name | 1 | 20150609 |
| 30c51294-7ae9-8007-7de6-58222684a0be | Product name | 1 | 20140508 |
| 4f26f669-fc6c-40ef-9e26-1c7b2390ee66 | Product name | 1 | 20140508 |
| 70a83adc-6047-bbea-5a08-dfd304aa47d2 | Product name | 1 | 20140508 |
| 858ce051-9941-aafc-8c7c-44a8e0227463 | Product name | 1 | 20140508 |
| b893258d-0942-3d8a-3411-056ea0788ff5 | Product name | 1 | 20140508 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 43598-823-14 | EA - Each | 43598-823 | 861c2254-d69f-4e3e-9994-c8d5c9889b20 | 1 | 2019-11-12 |
| 43598-823-31 | EA - Each | 43598-823 | 325cce27-681b-49d7-9fec-804e5ab7cdf8 | 1 | 2019-11-12 |
| 43598-823-35 | EA - Each | 43598-823 | 9970fa2c-cea3-458f-8a30-ff439217c409 | 1 | 2019-11-12 |
DailyMed Dashboard NDC Coverage#
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 997406 | fexofenadine HCl 60 MG / pseudoephedrine HCl 120 MG 12HR Extended Release Oral Tablet | PSN | 6fd05737-d996-b5b6-dccf-bc179a9d606c | 5 |
| 997406 | 12 HR fexofenadine hydrochloride 60 MG / pseudoephedrine hydrochloride 120 MG Extended Release Oral Tablet | SCD | 6fd05737-d996-b5b6-dccf-bc179a9d606c | 5 |
| 997406 | fexofenadine hydrochloride 60 MG / pseudoephedrine hydrochloride 120 MG 12 HR Extended Release Oral Tablet | SY | 6fd05737-d996-b5b6-dccf-bc179a9d606c | 5 |
| 997406 | fexofenadine HCl 60 MG / pseudoephedrine HCl 120 MG 12HR Extended Release Oral Tablet | PSN | 90e1aa06-b769-e8ac-af88-1d6a256b9487 | 1 |
| 997406 | 12 HR fexofenadine hydrochloride 60 MG / pseudoephedrine hydrochloride 120 MG Extended Release Oral Tablet | SCD | 90e1aa06-b769-e8ac-af88-1d6a256b9487 | 1 |
| 997406 | fexofenadine hydrochloride 60 MG / pseudoephedrine hydrochloride 120 MG 12 HR Extended Release Oral Tablet | SY | 90e1aa06-b769-e8ac-af88-1d6a256b9487 | 1 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Status |
|---|---|---|---|---|
| 43598-823-40 | 43598082340 | 35 TABLET, EXTENDED RELEASE in 1 CARTON (43598-823-40) | 19-OCT-22 | Current |